Synaptogenix, Inc.
SNPX
$2.50
$0.09023.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.84% | -6.64% | -18.63% | -47.06% | -65.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.17% | -4.90% | -13.59% | -42.11% | -63.79% |
| Operating Income | -2.17% | 4.90% | 13.59% | 42.11% | 63.79% |
| Income Before Tax | -456.88% | -852.36% | 68.90% | 87.92% | -122.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -456.88% | -852.36% | 68.90% | 87.92% | -122.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -456.88% | -852.36% | 68.90% | 87.92% | -122.22% |
| EBIT | -2.17% | 4.90% | 13.59% | 42.11% | 63.79% |
| EBITDA | -2.17% | 4.91% | 13.58% | 42.13% | 63.80% |
| EPS Basic | -187.08% | -442.87% | 96.58% | 93.78% | -109.40% |
| Normalized Basic EPS | -62.02% | -344.06% | 92.41% | 96.50% | -107.42% |
| EPS Diluted | -187.08% | -442.87% | 96.58% | 93.78% | -109.40% |
| Normalized Diluted EPS | -62.02% | -344.06% | 92.41% | 96.50% | -107.42% |
| Average Basic Shares Outstanding | 60.23% | 208.27% | 309.71% | 245.45% | 199.54% |
| Average Diluted Shares Outstanding | 60.23% | 208.27% | 309.71% | 245.45% | 199.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.00% | -- | -- | -- | -- |